Propanc Biopharma
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6 Butler St U 302, Camberwell, Victoria,...Phone Number
+61398820780Website
www.propanc.comRevenue
-Stock Symbol
PPCBIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Propanc Biopharma
Propanc Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Camberwell, Victoria, Australia, focused on developing novel treatments for patients with pancreatic, ovarian, and colorectal cancers. The company's lead product candidate, PRP, is an enhanced pro-enzyme formulation designed to work synergistically to target and eradicate cancer stem cells, aiming to prevent tumor recurrence and metastasis in high-risk cancer survivors. Rather than solely targeting tumor cell death, Propanc's approach focuses on inducing cell differentiation, encouraging malignant cells to stop proliferating. It maintains research collaborations with academic institutions to advance its pipeline, with PRP progressing toward a planned First-In-Human clinical study.Explore more
Propanc Biopharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Propanc Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Propanc Biopharma launches new products
Check if Propanc Biopharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Propanc Biopharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Propanc Biopharma had a recent Job posting/layoffs
Check out if Propanc Biopharma is spiking on competitors!
Propanc Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Propanc Biopharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Propanc Biopharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Propanc Biopharma
Compare insights from companies similar to Propanc Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Propanc Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Propanc Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Propanc Biopharma.
Propanc Biopharma financials insights
Gather financial insights about Propanc Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$1.2M
2020
Private Equity
$3M
2021
Private Equity
$5M
2025
Other Financing Round
$100M
Propanc Biopharma Tech Stack
A closer look at the technologies used by Propanc Biopharma
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Medical Research
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Event
Events
Propanc Biopharma News & Media
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
The world-first clinical study is a Phase 1b, open‑label, dose escalation and dose expansion study of PRP in patients with advanced solid tumors.Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers
Further improvements can be made with complementary treatment modalities such as PRP that target the way cancer cells become malignant, invasive and spreadPropanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
The data reinforces PRP’s differentiated mechanism targeting cancer stem cells, disrupting fibrotic microenvironment, and potentially overcoming resistancePropanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
The data reinforces PRP’s differentiated mechanism targeting cancer stem cells, disrupting fibrotic microenvironment, and potentially overcoming resistance
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Propanc Biopharma
Sign Up For FreeTo access detailed company insights
Propanc Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Camberwell, Victoria, Australia, focused on developing novel treatments for patients with pancreatic, ovarian, and colorectal cancers. The company's lead product candidate, PRP, is an enhanced pro-enzyme formulation designed to work synergistically to target and... Read More
